Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Gynecologic Oncology 2018

About Conference


OMICS International invites all the participants across the globe to attend the " Experts Meeting on Gynecologic Oncologyslated on july 18-19, 2018 at Atlanta, USA.

Annual conference on gynecologic oncology 2018 provides a forum of exchange of information among scientists, physicians and oncologists to present and discuss their Constructive, empirical, experimental, or theoretical work in every aspect of Gynecologic oncology thus upgrading the quality and administrations to the pertinent research works. Gynecology 2018 offer a front line program of prestigious worldwide speakers, pro simultaneous sessions, short paper and notice introductions drawing in more than 450 specialists in fruitfulness helped origination, sexual wellbeing and conceptive Science and Gynecology field. An extensive list of topics will be discussed that includes cervical cancer, ovarian cancer, uterine/endometrial cancer, Maternal Fetal Medicine, gynecology cancers, Endometriosis, preventive medicine oncology with the goal of improving the scientific network to all the concerned people to be a part of the conference and making it sensational with your presence.

ConferenceSeries Ltd  which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical (Cancer meeting,cancer conferences, oncology society, European oncology conferences, surgical oncology,global cancer conference, cancer conferences, American oncology society), Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe.

WHY TO ATTEND??

With individuals from around the globe concentrated on finding out about Women's Health and its advances; this is your best chance to achieve the biggest array of members from the Women's Health people group. Direct introductions, appropriate data, meet with present and potential researchers, make a sprinkle with new disclosures in the bosom growth treatment and finding, and get name acknowledgment at this 3-day occasion. Every single decent creator is urged to contribute and shape the meeting through entries of their exploration digests, papers and e-blurbs. This will be a decent stage for you to refresh the important research information and their clinical applications and intelligent minutes will illuminate the instabilities.

Target Audience:

The 4th Annual conference on gynecologic oncology 2018 is intended for

  • Pathologists
  • Medical Colleges
  • Nurse practitioners
  • Healthcare Faculty
  • Training Institutes
  • Breast cancer surgeons
  • Oncology social worker
  • Business Entrepreneurs
  • Scientists and Professors
  • Gynecologic Oncologists
  • Data Management Companies
  • Software Developing Companies  
  • Medical Devices Manufacturing Companies

Sessions/Tracks

1. Gynecologic oncology

Gynecology Oncology is the study about any cancer that begins in a woman's reproductive organs. The five Gynecologic cancers start in the woman's pelvis at different places. Each cancer is unique by its symptoms, signs, risk factors and in their strategies of prevention. All these five different types of Gynecology Cancers risk increases with the age. When these cancers were diagnosed at their early stages, the treatment will be more efficient. The five major types of cancer affect a woman's reproductive organs are ovarian, uterine, cervical, vulvar, and vaginal cancerAll these as a group are known as Gynecologic cancers

  • Operative Gynecology
  • Pregnancy Care and Delivery
  • Endocrinology of Pregnancy
  • Oncology Scan – Gynecological Cancers
  • Gynecology cancers

2. Gynecologic surgery

In Oncology Gynecology the Gynecologic Surgical methods include- Initial Debulking surgery,   which may be performed by variety of procedures depending on the type & stage of ovarian cancer based on individual fertility concerns. The procedure for removal of ovary and fallopian tube is known as bilateral salpingo-oophorectomy surgery. The surgical removal of uterus and cervix is known as Total hysterectomy. Lymph node biopsy will be performed by collecting the fluid sample from the abdomen. Omentectomy is surgical process for removing of omentum partially or as a whole. Fold of fatty tissue inside the abdomen is known as Omentum.  

Also this field is rapidly changing a result of new progressions and advancements in endoscopy, apply self-governance, imaging and other interventional frameworks. Gynecological surgery encompasses each surgical medication identifying with women's prosperity, including uro-gynecology, oncology and fetal surgery.

  • Micro surgery
  • Endometrial Biopsy
  • Vacuum Aspiration
  • Salpingoophorectomy
  • Laparoscopic & Laser Surgery
  • In vitro fertilization
  • Tubal logation

3. Clinical gynecologic oncology

 Clinical Gynecologic Oncology is a specialized clinical field of medication that emphasis on cancers of the female reproductive system. Gynecology Oncology is the find out about any infection that begins in a woman's regenerative organs. Each tumor is stand-out by its signs, risk parts and in their frameworks of revolution. All these five interesting sorts of Gynecology Cancers chance additions with the age. Exactly when these malignancies were broke down at their underlying stages; the treatment will be more proficient. The five essential sorts of tumor influence a woman's regenerative organs are ovarian, uterine, cervical, vulvar, and vaginal development. All these as a social event are known as Gynecologic developments.

  • Signal Transduction Pathways
  • Cancer in Pregnancy
  • Blood component therapy
  • Adolescent gynecology

4. Reproductive cancers

Women with early cervical malignancies and pre-maladies usually have no appearances. Appearances consistently don't begin until a pre-tumor transforms into a bona fide nosy sickness and forms into neighboring tissue. Exactly when this happens, the most broadly perceived appearances includes Abnormal vaginal biting the dust, for instance, leaking after sex, leaking after menopause, depleting and spotting among periods, and having longer or heavier (menstrual) periods than normal. Leaking in the wake of douching, or after a pelvic exam is an average reaction of cervical tumor however not pre-ailment. An interesting discharge from the vagina − the discharge may contain some blood and may occur between your periods or after menopause; Pain in the midst of sex.

  • Cervical Cancer
  • Uterine cancer
  • Vulvar Cancer
  • Vaginal Cancer
  • Fallopian tube
  • Ovarian cancer

5. Maternal fetal medicine

Maternal-fetal medication is an immense and proficient in gynecology and the Number of Research foundations dealing with the Maternal-fetal drug are roughly at least 33 and also a few colleges which are offering preparing to ladies to be Professionals in Maternal-fetal prescription , Maternal-fetal medication is a branch of obstetrics which underscore on medicinal and surgical administration of high-hazard pregnancy cases. Obstetricians who are honing maternal-fetal pharmaceutical are additionally called as primatologists. This is sub-strength of obstetrics and gynecology which is basically utilized for patients with high hazard pregnancies. Obstetric solution is related to fame that spotlights on the care of medicinal issues in pregnancy.

  • Signaling, Status and Inequities in Maternal Healthcare
  • Maternal Fetal Medicine Practice & Procedures
  • Fetal Blood Sampling
  • Pregnancy Termination Practice
  • Prenatal screening

6. Reproductive medicine

Reproductive Medicine in Gynecology is The quantity of Research organizations which are taking a shot at conceptive solution are roughly 120 and the quantity of Universities are around 20-30 which have the bureau of Medicine and the subsidizing towards this examination is over $90000 - $110000, Target gathering of people are of Academia 20%, half industry and 30% of others. Regenerative drug is a branch of solution which concentrates on counteractive action, analysis and administration of the conceptive issues. The objectives incorporate enhancing or keeping up conceptive wellbeing and enabling individuals to have youngsters during a period of their decision as talked about in numerous gynecologic gatherings around the world. It is centered on learning of conceptive life structures, physiology and endocrinology which likewise consolidates important parts of atomic science, organic chemistry and pathology. Regenerative solution stresses on procedure of supplanting, building or recovering human cells, tissues or organs to re-establish typical capacity.

  • Reproductive endocrinology
  • Reproductive cloning
  • Regenerative medicine and their application
  • Genitourinary medicine
  • Andrology
  • Sexual dysfunction

7. Ovarian cancer

Ovarian cancer is the ninth most normal malignancy in ladies, and the fifth driving reason for female growth passing. Recognition of ovarian malignancy while it is in its beginning periods fundamentally enhances visualization. Sadly, most instances of ovarian tumour are found when the growth is now best in class. Some more established examinations demonstrated that utilization of the richness sedate clomiphene (Clomid) could build the hazard for ovarian malignancy. Be that as it may, barrenness itself is a hazard factor for ovarian growth, so it is not sure whether ripeness drugs assume an extra part in influencing hazard. Later investigations recommend that richness drugs don't increment ovarian growth chance. The more circumstances a lady conceives an offspring, the more outlandish she is to create ovarian malignancy. Bosom sustaining for a year or more in the wake of conceiving an offspring may likewise diminish ovarian tumor hazard. There is uncertain proof with reference to whether natural variables increment the hazard for ovarian malignancy.

  • Breast cancer
  • Hormone replacement therapy
  • Abdominal fluid aspiration
  • Gene mutations
  • Targeted therapy
  • Prophylactic oophorectomy

  8. Infertility

Infertility can be depicted as a lady who can't imagine and being unable to convey a pregnancy in full term. Infertility is the failure of a man, plant or a creature to repeat by normal means. It is regularly not the natural condition of a sound grown-up creature, with the exception of in especially among certain social species Understanding the socio statistic factors parallel with utilize may help recently wedded couples with family arranging. As examined in numerous gynecologic gatherings and gynecologic gatherings around the world, the utilization of fruitlessness administrations is not irregular and generally around half of the ladies assessed for Infertility advanced to treatment, and in which just a little extent were treated with extra progressed helped conceptive innovations basically Ladies who are prolific will encounter a characteristic time of richness earlier and amid ovulation, and they will be actually infertile amid the last piece of the menstrual cycle. Therapeutic and surgical administration of substantial menstrual draining is portrayed including the many changed issues in hysterectomy of obese women.

  • Infertility Evaluation and Management
  • Tubal Infertility and Ectopic Pregnancy
  • Artificial Gametes and Ovarian Stimulation
  • Obesity and surgical management of Infertility
  • Infertility Evaluation and Treatment Among Women

9. Ablative technologies in gynecology

The development of robotic technology has facilitated the application of minimally invasive techniques for complex operations in gynecologic oncology. The regarding robotic surgery and its application to gynecologic cancer Computer-enhanced technology with its associated benefits appears to facilitate the surgical approach for technically challenging operations performed to treat selected cases of cervical, endometrial, and ovarian cancer as evidenced by the current literature. Continued research and clinical trials are needed to further elucidate the equivalence or superiority of robot-assisted surgery to conventional methods in terms of oncologic outcome and patients' quality of life.

  • Menorrhagia
  • Endometrial Laser Ablation
  • Transrectal Ultrasonography
  • Current and emergent treatment trends
  • Clinical applications of ablative technologies
  • Transurethral Needle Ablation 

10. Pediatric gynecology

Pediatric gynecology is the medical practice dealing with the soundness of the vagina, vulva, uterus, ovaries of new-born children and adolescents. The Gynecologic tumors begin in the lady's pelvis at better places. Every tumour is emerging by its signs and hazard parts and in their structures of revolution. Precisely when these malignancies were penniless down at their hidden stages, the treatment will be more capable. The five fundamental sorts of tumour influence a lady's regenerative organs are ovarian, uterine, cervical, vulvar, and vaginal advancement. All these as a get-together are known as Gynecologic improvements. The establishment of paediatric oncology explore is precise information of the study of disease transmission of adolescence tumours in the nation. Lamentably, there is a genuine scarcity of epidemiologic information on paediatric malignancies in India. There was for all intents and purposes no information on frequency or circulation of paediatric growths until 1982, when the National Cancer Registry Program (NCRP) was begun

  • Hernia
  • Vulvitis
  • Amenorrhea
  • Contraception
  • Prepubertal Anatomy
  • Intersex conditions

11. Health related behaviours in women

Behavioural Health is expressed as the issues that can have an alternate result by evolving different behaviour. For instance, surrendering smoking can diminish the ailments or Health Problems related with cigarette smoking as talked about in numerous gynecologic gatherings  around the world. Numerous wellbeing conditions are caused by chance practices, for example, smoking, neglectful driving, issue drinking, substance utilize, blowing up, or unprotected sex. Luckily, individuals have control over their direct. Wellbeing trading off practices can be destroyed without anyone else's input administrative endeavours and wellbeing improving practices that can be received, for example, preventive sustenance, physical exercise, weight control, dental cleanliness, condom utilize or mischance counteractive action.

Lifestyle related diseases associated with physical inactivity and poor diet quality, represent a major health burden. Furthermore, self-management and emphasizing the pivotal role patients have in managing their illness is important for optimizing health outcomes.

  • Physical activity in women
  • Psychology of women during pregnancy
  • Mental health issues
  • Alcohol use

12. Gynecologic cancer: case report

Women with early cervical malignancies and pre-infections as a rule have no appearances. Indications routinely don't begin until a pre-tumour transforms into a bona fide meddling illness and forms into contiguous tissue. Right when this happens, the most broadly perceived appearances are: Abnormal vaginal biting the dust, for instance, leaking after sex (vaginal intercourse), seeping after menopause, depleting and spotting among periods, and having longer or heavier menstrual periods than normal. Leaking in the wake of douching, or after a pelvic exam is an average reaction of cervical tumor however not pre-infection. A bizarre discharge from the vagina − the discharge may contain some blood and may occur between your periods or after menopause; Pain in the midst of vaginal intercourse.

  • Gynecologic Cancers Case Report on Prevention
  • Gynecologic Cancers Case Report on Screening
  • Gynecologic Cancers Case Report on Diagnosis
  • Gynecologic Cancers Case Report on Treatment

  13.  Ectopic pregnancy

Ectopic pregnancy is an exceptionally normal determination (2% of pregnancies), and implantation area shifts. Though 97% of ectopic are embedded inside the fallopian tube, related with regularly perceived hazard factors, ectopic implantation can happen in other pelvic and stomach areas that might not have such inclining hazard factors. After a broad audit of the writing, implantation recurrence, etiologic conceivable outcomes, and treatment alternatives for each ectopic pregnancy area are introduced. At the point when ectopic pregnancy is analysed ahead of schedule, before burst, paying little heed to area, preservationist, richness saving treatment choices can be fruitful in ending the pregnancy. Inclining hazard elements and treatment alternatives can differ and can be ectopic-area particular.

  • Endometriosis
  • Laparoscopy
  • Ultrasonography
  • Pelvic inflammatory disease
  • Transvaginal ultrasonography
  • Tubal and non-tubal ectopic pregnancy

14. Endometrial cancer

Endometrial cancer is the fourth most regular growth in ladies, with an expected 34,000 cases and 6000 passing in the United States in 1996. It is the most reparable of the 10 most basic malignancies in ladies and the most incessant and treatable of the gynecologic diseases. Ninety-seven percent of all malignancies of the uterus emerge from the organs of the endometrium and are known as endometrial carcinomas. Numerous adjustments in the neurotic depiction of endometrial growth, recognizable proof of prognostic factors, arranging, and treatment have happened. Unopposed exogenous estrogen managed for the treatment of menopausal side effects as mainstream in 1960s is been perceived as a pathogenic factor. This practice increased in the incidence of endometrial carcinoma in the United States to 39,000 per cases and this has been reported which attributed to increasing longevity in women.

  • Carcinoma
  • Endometrial biopsy
  • Abdominal hysterectomy
  • Radiation therapy
  • Hormone therapy

15. Gynecologic cancer prevention and control

A move from treatment to counteractive action of the three noteworthy gynecologic diseases: Cervical tumour remains the fourth most regular disease, influencing ladies worldwide with vast geographic varieties in cervical malignancy frequency and death rates.. Similarly as with other such infections, obstruction and spermicidal contraceptives bring down the danger of cervical tumour; the hazards decrease approximate 50%. Combinational contraceptives help anticipate both endometrial and epithelial ovarian tumours. The danger of endometrial tumour among previous oral preventative clients is decreased by around 50% and that of ovarian malignancy by around 30% to 80%. Weight control presents solid assurance against endometrial growth. Breast feeding and tubal sterilization seems to ensure against ovarian growth. In spite of the fact that ladies have a scope, of practical, effective measures accessible to diminish their danger of these malignancies, and few know about them. A few confirmation based mediations are accessible to lessen the occurrence, dreariness, and mortality from these growths. The National Comprehensive Cancer Control Program (NCCCP) is remarkably situated to actualize these interventions in the US population.

  • Prevention of cervical cancer
  • Prevention of vulvar cancer
  • Prevention and early detection of vaginal cancer
  • Prevention of epithelial ovarian cancer
  • Risk assessment

16. New technologies in reproductive cancer

Computer upgraded telesurgery, called robotic assisted surgery, is the most recent development in the insignificant intrusive surgery field. In gynecology, this machine has been connected in a few applications, in the fields of benign gynecology, regenerative pharmaceutical, urogynecology, and oncology. In general, there were more twisted difficulties in the laparotomy approach contrasted with laparoscopy and mechanical helped laparoscopy. Irresistible and lung-related dismalness, postoperative ileus, and dying/clump development was all the more regularly detailed in the laparotomy gather analysed the other two associates in endometrial malignancy patients. Computer assisted improved innovation may empower more specialists to change over their laparotomies to laparoscopic surgery with its related advantages. It gives the idea that in the hands of experienced laparoscopic specialists, ultimate results are a similar when utilizing or not utilizing the robot. There is great proof that mechanical surgery encourages laparoscopic surgery, with proportional if worse agent time and similar surgical results, and less significant difficulties than those surgeries using the laparotomy approach.

  • Robotic- assisted surgery
  • Stereotactic body therapy
  • New techniques for cervical cancer screening
  • Assisted reproductive technologies

17. Menstrual disorders

Introduction with a menstrual unsettling influence may camouflage different issues, for example, those identifying with contraception, pregnancy, sexually transmitted disease or even rape, and the gynecologist ought to guarantee that the young lady is given the chance to raise different concerns. This may incorporate a private meeting far from any relative or companion who might be going with her to the interview. The menstrual cycle includes the coordination of numerous occasions by the hypothalamic-pituitary ovarian pivot and it is promptly impacted by physiological and neurotic changes happening amid the conceptive life expectancy. The period of menarche is dictated by general wellbeing, hereditary, financial and dietary elements. There has been a lessening in the mean period of menarche at a rate of four months for every decade throughout the most recent 100 years in the USA, for the most part owing to change in dietary status.

  • Menopause
  • Amenorrhea
  • Premenstrual syndrome
  • Polycystic ovary syndrome
  • Pelvic Floor Dysfunction
  • Premenstrual Dysphoric Disorder

18. Biomarkers

Cancer is a gathering of illnesses portrayed by the uncontrolled development and spread of irregular cells and oncology is a branch of medication that arrangements with tumours. The most recent decade has seen huge advances in the improvement of biomarkers in oncology that assume a basic part in understanding atomic and cell systems which drive tumour start, support and movement. Clinical sub-atomic diagnostics and biomarker revelations in oncology are progressing quickly as we comprehend the intricate instruments that change an ordinary cell into an anomalous one. These revelations have powered the improvement of novel medication targets and new treatment procedures. Late advances in multiplex genotyping advances and high-throughput genomic profiling by cutting edge sequencing make conceivable the fast and far reaching investigation of the disease genome of individual patients even from next to no tumour biopsy material. Prognostic biomarkers distinguish substantial germ line transformations, changes in DNA methylation, raised levels of microRNA and flowing tumour cells in blood. Prescient biomarkers utilizing atomic diagnostics are as of now being used in clinical routine with regards to customized oncotherapy for the treatment of five maladies: ceaseless myeloid leukemia, colon, bosom, lung tumour and melanoma.

  • Therapeutic molecular biomarkers
  • Cancer epidemiology biomarkers
  • Biomarkers of cancer stem cells
  • Prognostic biomarkers in ovarian cancer
  • Emerging biomarkers for gynecologic cancers

 

Market Analysis

The worldwide market for gynecological gadgets includes an exceptionally divided merchant scene, with the main three organizations, to be specific Olympus Corporation, Boston Scientific Corporation, and Cooper Surgical represented more than 25.5% of the market's general income in 2014, watches Transparency Market Research in a current report. Albeit territorial players and new merchants represent a critical offer in the market's income directly, passage obstructions are ending up noticeably more extraordinary for new organizations, the market offers tremendous development openings as the rising interest for imaginative items and the expanding reception of noninvasive gadgets over the globe. In addition, with the ascent in the quantity of patients settling on customary registration, particularly crosswise over creating economies, is likewise anticipated that would make a tremendous arrangement of chances for merchants in the worldwide.

 

 

 The cytostatic hormonal market enlisted 2010 offers of $8bn at a Y-o-Y lessening of 6.5%. AstraZeneca's Arimidex (anastrozole) and Novartis' Femara (letrozole) had driven this class, accomplishing offers of $1.5bn and $1.3bn independently in 2010. The overall Gynecologic threat publicize in 2010 was regarded at $54bn, an extension of 5.1% over the prior year's offers of $51.3bn, and is guage to create at a CAGR of 6.9% from 2010–16, accomplishing $81bn in 2016. Aggregately, the seven vital markets (US, 5EU, and Japan) addressed 79.1% (or $43bn) of in the overall development grandstand in 2010. To the extent estimate, the US governed the overall infection feature, with 2010 offers of $21bn and a bit of the pie of 38.5%. The overall sickness promote is winding up logically forceful, with two supportive classes, specifically antineoplastics and cytostatic hormonal drugs, overpowering this fragment. All around, the primary 10 brands spoke to appropriate around 58.2% (or $31.4bn) of the overall threat feature in 2010. In 2010 antineoplastics was the fundamental solution class in the overall development publicize. The overall antineoplastic market was regarded at $46bn in 2010 at a year-on-year (Y-o-Y) improvement of 7.3%. The huge solutions that additional to the 2010 arrangements in the antineoplastic class were Roche's Avastin (bevacizumab) at $6.2bn, Herceptin (trastuzumab) at $5.2bn, and MabThera (rituximab) at $5.1bn, with Y-o-Y bargains improvement of 3.8%, 3.1%, and 3.3% independently

GYNECOLOGIC CANCER STATISTICS

Gynecologic malignancies are sorted by uncontrolled development and spread of irregular cells. These growths begin in the female conceptive organs, for example uterus, cervix, ovaries, vagina, vulva and Breast malignancy. A few components are in charge of the event of these growths. The strange capacity of these qualities controls through maturing, smoking and natural impacts. In including, barrenness, stoutness, changes, encouraging start of period and poor start of menopause likewise causes gynecologic tumors.

Gynecologic growths are additionally begun by some infections. For example, every single cervical growth, vaginal and vulva malignancies are caused by human papillomavirus (HPV). These gynecologic diseases are dealt with by drug treatments, radiation treatment, surgeries and chemotherapy. Medicines of these tumors are relies on the sort and distinctive phases of cancers. In terms of geographic, North America and Europe commands the worldwide gynecologic malignancies advertise. The U.S. speaks to the biggest market for gynecologic growths took after by Canada in North America. In Europe, France, Germany and the U.K. holds real offer of gynecologic malignancies advertise. Nonetheless, Asia is required to indicate high development rates in the following five years in worldwide gynecologic diseases advertise. This is because of expanding mindfulness among individuals about different sorts of gynecologic malignancies in the locale. Japan, China and India are relied upon to be the quickest developing gynecologic growth advertises in Asia.

 

 

Hospitals Associated with Gynecologic Oncology Research

Major Gynecologic Oncology associated hospitals in Chicago are around 2% when compared to worldwide.

 Hospitals in Chicago and USA are:

  • Methodist Hospital
  • Southwest General Hospital
  • Cancer Care Centre of South Texas
  • Methodist Women's centre
  • Metropolitan Methodist Hospital
  • South Texas Oncology Group
  • Advocate Good Samaritan Hospital
  • Anderson Hospital
  • Aspirus Wausau Hospital
  • Aultman Hospital
  • Aurora St. Luke's Medical Center
  • Banner Good Samaritan Medical Center
  • Barnes-Jewish Hospital
  • Beaumont Hospital
  • Bon Secours Memorial Regional Medical Center
  • Boone Hospital Center
  • Boston Medical Center
  • Brigham and Women's Hospital
  • Bryn Mawr (Pa.) Hospital
  • Carle Foundation Hospital
  • Cedars-Sinai Medical Center
  • Christiana Hospital
  • Dartmouth-Hitchcock Medical Center
  • Duke University Hospital
  • Emory University Hospital
  • Evanston (Ill.) Hospital
  • Fairview Southdale Hospital
  • Flagler Hospital
  • Florida Hospital
  • Glendale (Calif.) Memorial Hospital and Health Center
  • Gundersen Lutheran Medical Center
  • Hackensack (N.J.) University Medical Center
  • Halifax Health Medical Center of Daytona Beach
  • Hutzel Women's Hospital
  • Hartford (Conn.) Hospital
  • Holy Cross Hospital
  • Hospital of the University of Pennsylvania
  • Huntington Hospital
  • Indiana University Health Methodist Hospital/University Hospital (Indianapolis)
  • Ingalls Memorial Hospital
  • Inova Fairfax Hospital
  • Johns Hopkins Hospital
  • Keck Hospital of the University of Southern California
  • Lancaster (Pa.) General Hospital
  • LDS Hospital
  • Magee-Womens Hospital of UPMC
  • Massachusetts General Hospital
  • MedStar Georgetown University Hospital
  • Memorial Hermann Memorial City Medical Center

 

 

Societies Associated with Gynecologic Oncology Research

In world there are about 9,685 societies which are specifically associated with Gynecologic Oncology, in which 1289 societies are from USA and the remaining 269 societies are from Chicago.

American gynecologic and obstetrics society

American society of clinical oncology

National cancer institute

Society of Gynecologic Oncology

Society of Gynecologic nurse Oncologists

International Gynecologic cancer society

American college of Phlebology

American congress of Obstetricians and Gynecologists

Asian Society of Gynecologic Oncology

Female Genital Tract Pathology

Foundation for Women's Cancer

GYN-ONC - Gynecologic Cancers Support Group

Gynecologic Oncology

Gynecologic Oncology Group

Northern Gynecologic Oncology Centre

Queensland Centre for Gynecologic Oncology

 

 

Industries Associated with Gynecologic Oncology Research

Industries associated with Gynecologic cancer all over the world is about 85% in which 12% of industries are in USA and in Chicago about 3%.

·        Johnson & Johnson

·        Novartis

·        Roche

·        Pfizer

·        Sanofi

·        Merck

·        Bristol-myers squibb

·        Eli Lilly

·        Celgene

·        Takeda

·        AstraZeneca

·        Merck & Co.

·        Amgen

·        Bayer

·        Otsuka

·        Pharmacyclics

·        Incyte

 

 

Universities Associated with Gynecologic Oncology Research

Gynecologic cancer associated universities in world are about 3284, in USA 612 universities.

Trinity University

St. Mary's University

Our Lady of the Lake University

Baptist University of the Americas

University of Texas Medical Branch

University of Texas Medical School at Houston

University of Texas Rio Grande Valley School of Medicine

Dell Medical School at the University of Texas at Austin

University of Alabama School of Medicine

University of Arizona College of Medicine

Charles R. Drew University of Medicine and Science

Keck School of Medicine of University of Southern California

Loma Linda University School of Medicine

Stanford University School of Medicine

UC Davis School of Medicine

University of California, Irvine School of Medicine

David Geffen School of Medicine at UCLA

UC Riverside School of Medicine

University of California, San Diego School of Medicine

University of Colorado School of Medicine

Frank H. Netter M.D. School of Medicine at Quinnipiac University

University of Connecticut School of Medicine

Yale School of Medicine

George Washington University Medical School

Georgetown University School of Medicine

Howard University College of Medicine

The University of Texas at San Antonio

The University of Texas Health Science centre at San Antonio

Florida Atlantic University Charles E. Schmidt College of Medicine

Florida State University College of Medicine

University of Florida College of Medicine

University of South Florida College of Medicine

Mercer University School of Medicine

Loyola University Chicago Stritch School of Medicine

North-western University Feinberg School of Medicine

Rush Medical College

Indiana University School of Medicine

University of Iowa Roy J. and Lucille A. Carver College of Medicine

University of Kansas School of Medicine

University of Kentucky College of Medicine

University of Louisville School of Medicine

Louisiana State University School of Medicine in New Orleans

Tulane University School of Medicine

Johns Hopkins University School of Medicine

Boston University School of Medicine

Harvard Medical School

Oakland University William Beaumont School of Medicine

Wayne State University School of Medicine

Mayo Clinic College of Medicine

University of Minnesota Medical School

University of Mississippi School of Medicine

University of Missouri-Columbia School of Medicine

Rutgers New Jersey Medical School

University of New Mexico School of Medicine

Icahn School of Medicine at Mount Sinai

New York Medical College

New York University School of Medicine

 

 

Past Conference Report

Gynec & Preventive Oncology 2017 Report

The success of the Gynecologic Oncology conference has given us the prospect to bring the gathering one more time. Conferenceseries LLC hosted the “3rd Annual Conference on

Gynecologic Oncology & Preventive Oncology” during July 20-21, 2017at DoubleTree by Hilton Chicago, Chicago, USA

The conference was focused on Gynecologic Cancers, Breast cancer Research and Preventive Oncology studies with the theme “Revolutionary Essence of Motivating the Living and Good Health of Women”. The meeting engrossed a vicinity of comprehensive discussions on novel subjects like ovarian cancer, Breast cancer, uterine cancer, vaginal cancer, cervical cancer, Pediatric Oncology, Stem Cell Therapy, Biomarkers, Oncology Nursing and vulvar cancer.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

·         Dr. Aaron Chevinsky, Aurora Health Care, USA

·         Dr. Colleen Huber , Naturopathic Oncologist (FNORI), USA

·         Dr. Denise L. Johnson Miller, Hackensack Meridian Health System, USA

·         Dr. Homer S. Black, Baylor College of Medicine, USA

·         Dr. Nick Kostovic, Kostovic Acupuncture by bio Electron’s Laser, Corp., USA

Best Poster Awardees:

·         Dr. Yoshiaki Omura, Family & Community Medicine, New York Medical College, USA

Conferenceseries LLC offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conferenceseries LLC and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Gynec & Preventive Oncology 2017, Conferenceseries LLC would like to announce the commencement of the “4th Annual Conference on Gynecologic Oncology & Preventive Oncology” to be held during July 18-19, 2018 Atlanta, USA. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Gyneocology Research and Oncology.

For More details: http://gynecologic-oncology.conferenceseries.com/

Let us meet again @ Gynec & Preventive Oncology-2018

 

To Collaborate Scientific Professionals around the World

Conference Date July 18-19, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Gynecology & Obstetrics Advances in Cancer Prevention Journal of Cancer Science & Therapy

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


What People Say....

Thank you for organizing a successful conference! My talk went well and I got to meet and interact with other scientists in closely related aspects of oncology, which was interesting and informative.

Speaker

Joseph O Nwankwo, Federal University, Nigeria

Gynec & Preventive Oncology 2017 was very successful conference. It opened road for new experiences, research and discovered technology as it is mine. Gynec & Preventive Oncology 2017 will have always most prominent place in my participation. I had developed K-BTE medical laser device and this new technology will rescue lives of million woman and man from different malignant cancer.

Speaker

Nick kostovic- Acupuncture by bio Electron’s Laser, Corp., USA